David Gill

David Gill is currently the Director at Evolus. Prior to this, they were the Chairman at Bio2 Technologies from December 2019 to June 2021. David also has experience as a board member and chairman of audit committee at Theirtogenics Corporation from February 2015 to July 2019. Lastly, they were the President, COO & CFO at Endochoice Holdings Inc. (GI) from August 2014 to November 2016.

David Gill has a MBA from Emory University - Goizueta Business School and a Bachelor of Science in Accounting from Wake Forest University. David is also certified from the North Carolina Association of CPA in CPA.